JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (3): 14-18.doi: 10.6040/j.issn.1671-7554.0.2015.833
Previous Articles Next Articles
ZONG Zhaoyun1, LI Xia2, HAN Zhenlong3, WANG Xianteng1, GUO Chun1, ZHANG Lining1, SHI Yongyu1
CLC Number:
[1] Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917. [2] Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma[J]. The Lancet, 2012, 379(9822): 1245-1255. [3] 缪俊俊, 李国利, 贾筱琴. 肿瘤相关巨噬细胞在肝癌中的研究进展[J]. 肿瘤预防与治疗, 2014, 27(4): 204-208. MIAO Junjun, LI Guoli, JIA Xiaoqin. The process of tumor-associated macrophages in hepatocellular carcinoma[J]. Journal of Cancer Control and Treatment, 2014, 27(4): 204-208. [4] Sachdeva M, Chawla YK, Arora SK, Immunology of hepatocellular carcinoma[J]. World J Hepatol, 2015, 7(17): 2080-2090. [5] Wang H, Wang X, Li X, et al. CD68+ HLA-DR+ M1-like macrophages promote motility of HCC cells via NF-kappaB/FAK pathway[J]. Cancer Lett, 2014, 345(1): 91-99. [6] 舒孟军, 郭圣荣. c-Met信号通路及其抑制剂的研究进展[J]. 上海交通大学学报(医学版), 2013, 33(8): 1167-1170. SHU Mengjun, GUO Shengrong. Research progress of c-Met signaling pathway and antagonists[J]. Journal of Shanghai Jiaotong University(Medical Science), 2013, 33(8): 1167-1170. [7] Graveel CR, Tolbert D, Vande GF, et al. MET: a critical player in tumorigenesis and therapeutic target[J]. Cold Spring Harb Perspect Biol, 2013, 5(7): 1-17. [8] Xie B, Xing R, Chen P, et al. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference[J]. J Surg Res, 2010, 162(2): 231-238. [9] Davis MJ, Tsang TM, Qiu Y, et al. Macrophage M1/M2 polarization dynamically adapts to changes in cytokine icroenvironments in Cryptococcus neoformans infection[J]. MBio, 2013, 4(3): e00264-13. doi:10.1128/mBio.00264-13. [10] 周宪宾, 姚成芳. 巨噬细胞M1/M2极化分型的研究进展[J]. 中国免疫学杂志, 2012, 28(10): 957-960. [11] Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils[J]. Nat Immunol, 2011, 12(11): 1035-1044. [12] Murray PJ, Allen JE, Biswas SK, et al. Macrophage activation and polarization: nomenclature and experimental guidelines[J]. Immunity, 2014, 41(1): 14-20. [13] Gardner FP, Serie DJ, Salomao DR, et al. c-MET expression in primary and liver metastases in uveal melanoma[J]. Melanoma Res, 2014, 24(6): 617-620. [14] Balan M, Miery TE, Waaga-Gasser AM, et al. Novel roles of c-Met in the survival of renal cancer cells through the regulation of HO-1 and PD-L1 expression[J]. J Biol Chem, 2015, 290(13): 8110-8120. [15] Surriga O, Rajasekhar VK, Ambrosini G, et al. Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model[J]. Mol Cancer Ther, 2013, 12(12): 2817-2286. [16] Moran-Jones K, Brown LM, Samimi G. INC280, an orally available small molecule inhibitor of c-MET, reduces migration and adhesion in ovarian cancer cell models[J]. Sci Rep, 2015, 5: 11749. doi:10.1038/screp11749. [17] Tsai PC, Fu YS, Chang LS, et al. Cardiotoxin III inhibits hepatocyte growth factor-induced epithelial-mesenchymal transition and suppresses invasion of mda-mb-231 cells[J]. J Biochem Mol Toxicol, 2016, 30(1): 12-21. |
[1] | LÜ Shuqing, WEI Wei, ZHANG Cancan, TIAN Yongjie. Mechanism of HGF/PARP-1 signaling pathway regulating invasion and metastasis of ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 1-7. |
[2] |
HAN Yan-xin, CONG Ya-qin, WANG Zhi-min.
Immuno-suppressive effects mediated by mesenchymal stem cells of myelodysplastic syndrome patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(6): 97-. |
[3] | LIU Bin, LIU Wei, FAN Hai-tao, HOU Xian-zeng, JIA Jian-bo, XU Shang-chen, PANG Qi. Expression of HGF, C-Met, VEGF-A and their correlations with malignancy and angiogenesis in astrocyte tumors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(2): 109-. |
[4] | LIU Jin-feng1, ZHANG Nan2, XU Chao3, LI Zhe2, LIU Jie2, SUN Yu-ping2. Co-expression of hypoxia-inducible factor-1α and hepatocyte growth factor in non-small-cell lung cancer and their association with lymphangiogenesis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(11): 112-. |
[5] | WANG Jing-nan 1, ZHANG Nan-2, ZHAO Jian-qiang 2, GAO Ai-qin 3, LIN Wen-li 3, SUN Yu-ping 2. Expressions of hepatocyte growth factor and its receptor c-met in breast carcinoma and their relationship to lymphangiogenesis and lymphatic metastasis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(3): 90-93. |
[6] | JIA Xueqin1, LIU Haiying2, MA Yuyan2, GAO Lingxue3, LIU Yuan2. Effects of the hepatocyte growth factor on expression of the homeobox gene HLX1 and invasion of trophoblast cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(2): 58-. |
[7] | LIN Wen-li1, ZHANG Nan2, QU Fei3, LIU Jie2, WANG Jing-nan4, XIE Tian-yan3, SUN Yu-ping2. Co-expression of hepatocyte growth factor and vascular endothelial growth factor-c in non-small cell lung cancer and their relationship with lymphangiogenesis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(10): 111-115. |
[8] | ZHANG Yan-sheng,LIU Shao-hua,WEI Feng-cai,SUN Shan-zhen. Expressions of HGF and its receptor in oral squamous cell carcinoma and neck lymph nodes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(4): 420-423. |
[9] | MA Feng, LIU Shao-Hua, WANG Ke-tao, WANG MIng-Guo, Shan Bao-Zhong, WEI Feng-Cai. Expression of hepatocyte growth factor mRNA in distraction osteogenesis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(12): 1149-1152. |
[10] | ZHANG Shi-qian,CHEN Xiu-juan,ZHOU Xiao-liang. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(7): 734-738. |
|